PEMDx develops respiratory monitoring solutions, including the Flow-Bag™ and ApnoLight™, that provide breath-by-breath assessments and accurate respiratory data without the need for setup. Their technology enhances patient safety by fitting standard oxygen face masks and offering a low-cost alternative to existing respiratory monitors.
Funding
$192K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current respiratory monitoring systems often require complex setup procedures and can be expensive, limiting their accessibility and ease of use in various clinical settings. This can lead to delays in obtaining accurate respiratory data, potentially compromising patient safety.
Solution
PEMDx offers respiratory monitoring solutions designed for ease of use and accuracy. Their Flow-Bag™ and ApnoLight™ devices provide breath-by-breath respiratory assessments without requiring extensive setup. These devices seamlessly integrate with standard oxygen face masks, offering a cost-effective alternative to traditional respiratory monitors while enhancing patient safety through real-time data acquisition. The technology allows for comprehensive respiratory monitoring in diverse clinical environments.
Target Audience
The primary target audience includes medical professionals such as doctors, anesthesiologists, and respiratory therapists in hospitals, clinics, and emergency care settings.
Features
- Breath-by-breath respiratory indications for immediate assessment.
- Enhanced accuracy in respiratory-related measurements.
- Universal compatibility with standard oxygen face masks.
- Zero setup time required for immediate deployment.
- Cost-effective alternative to existing respiratory monitoring systems.